Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT07095829
Recruiting Observational

Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum

NCT07095829 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2024-02-01
Last updated
2025-09-15

Condition(s) studied

Pulmonary Atresia With Intact Ventricular SeptumCongenital Heart DiseaseFetal Cardiac Disorder

Investigational drug(s) / intervention(s)

No intervention

No intervention: Evaluation of natural history of the disease

Study summary

Pulmonary atresia (PA)/critical stenosis (CS) with intact ventricular septum (PA/CS-IVS) is a rare congenital heart disease (CHD), that presents heterogeneously. Prognosis is conditioned by the possibility of achieving a primary repair with biventricular circulation (BV) or a one-and-a-half ventricle solution vs. a palliative approach bound to a univentricular (UV) circulation in which both survival and quality of life are significantly impaired. Predicting UV circulation prenatally is still a challenge.

The aim of this study is: 1/ to evaluate the natural history of the disease and develop a prognostic model for the prediction of transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age 2/ To develop a model to predict the risk of right ventricle dependent coronary circulation 3/ To evaluate prenatal and postnatal outcomes in non-intervened fetuses with a confirmed postnatal diagnosis of PA-CS/IVS including Intrauterine death, neonatal/Infant death, number of required postnatal procedures, need for oxygen support, need for cardiac transplantation

Eligibility

Sex
ALL
Min age
16 Weeks
Max age
28 Weeks
Healthy volunteers
No
Inclusion Criteria: * Absence of flow at the pulmonary valve (PA) or presence of thickened and domed. pulmonary valve cusps with a pinhole jet of flow. * Doppler evidence of ductal-dependent pulmonary circulation. * Intact ventricular septum. Exclusion Criteria: * Poor imaging windows and incomplete/poor quality scan * Termination of pregnancy * Cases initially included that undergo prenatal pulmonary valvuloplasty later on in pregnancy. * Unconfirmed PA-CS/IVS at birth. * Functional PA-CS/IVS (Ebstein malformation, monochorionic twins) * Any associated cardiac defect except persistent left superior vena cava and aberrant right subclavian artery. * Any significant (i.e that might influence outcome) extracardiac anomaly and/or known genetic syndromes. Also, if such a condition is present at inclusion but diagnosed only after birth, the case will be retrospectively excluded.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hospital Universitario 12 de Octubre Madrid Spain Recruiting
University of Gothenburg Gothenburg Sweden Active Not Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07095829 on ClinicalTrials.gov ↗ ← All trials in Sweden